CEREBROSPINAL FLUID GLUTAMINE AS A MEASURE OF HEPATIC ENCEPHALOPATHY

被引:127
|
作者
HOURANI, BT
HAMLIN, EM
REYNOLDS, TB
机构
关键词
D O I
10.1001/archinte.127.6.1033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1033 / &
相关论文
共 50 条
  • [41] Cerebrospinal Fluid Hypovolemia and Posterior Reversible Encephalopathy Syndrome
    Zheng, Yuan-yuan
    Weng, Xiong-peng
    Fu, Fang-wang
    Cao, Yun-gang
    Li, Yan
    Zheng, Guo-qing
    Chen, Wei
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [42] HEPATIC-ENCEPHALOPATHY - LACK OF CHANGES OF GAMMA-AMINOBUTYRIC-ACID CONTENT IN PLASMA AND CEREBROSPINAL-FLUID
    MORONI, F
    RIGGIO, O
    CARLA, V
    FESTUCCIA, V
    GHINELLI, F
    MARINO, IR
    MERLI, M
    NATALI, L
    PEDRETTI, G
    FIACCADORI, F
    CAPOCACCIA, L
    HEPATOLOGY, 1987, 7 (05) : 816 - 820
  • [43] Increased cerebrospinal fluid concentration of 3-methoxy-4-hydroxyphenylethyleneglycol in cirrhosis with subclinical hepatic encephalopathy.
    Tsuji, H
    Ogata, H
    Hashiguchi, M
    Shimono, J
    Fujishima, M
    HEPATOLOGY, 1998, 28 (04) : 665A - 665A
  • [44] REFERENCE VALUES FOR CEREBROSPINAL-FLUID GLUTAMINE CONCENTRATION IN INFANTS
    BOECKX, RL
    IOSEFSOHN, M
    HICKS, JM
    CLINICAL CHEMISTRY, 1980, 26 (05) : 601 - 603
  • [45] Oral glutamine challenge predicts risk and defines hepatic encephalopathy types
    Ampuero, J.
    Gomez, A. G.
    Viloria, M. Del Mar
    Camacho, I.
    Moro, A.
    Romero-Gomez, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S378 - S379
  • [46] Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy
    Gil-Gomez, Antonio
    Isabel Gomez-Sotelo, Ana
    Ranchal, Isidora
    Rojas, Angela
    Garcia-Valdecasas, Marta
    Munoz-Hernandez, Rocio
    Gallego-Duran, Rocio
    Ampuero, Javier
    Romero-Gomez, Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2018, 110 (07) : 427 - 433
  • [47] HEPATIC ENCEPHALOPATHY: CEREBROSPINAL FLUID METABOLOMICS HIGHLIGHTS ALTERATION OF MULTIPLE METABOLIC PATHWAYS REPRESENTING NEW POTENTIAL THERAPEUTIC TARGETS
    Weiss, N.
    Isnard, F.
    Attala, S.
    Colsch, B.
    Amador, M. del Mar
    Lamari, F.
    Rudler, M.
    Sedel, F.
    Junot, C.
    Thabut, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S332 - S332
  • [48] EVIDENCE FOR THE PRESENCE OF A BENZODIAZEPINE RECEPTOR-BINDING SUBSTANCE IN CEREBROSPINAL-FLUID OF A RABBIT MODEL OF HEPATIC-ENCEPHALOPATHY
    MULLEN, KD
    MARTIN, JV
    MENDELSON, WB
    KAMINSKYRUSS, K
    JONES, EA
    METABOLIC BRAIN DISEASE, 1989, 4 (04) : 253 - 260
  • [49] Pitfalls in Measuring Cerebrospinal Fluid Glycine Levels in Infants With Encephalopathy
    Aburahma, Samah
    Khassawneh, Mohammad
    Griebel, May
    Sharp, Gregory
    Gibson, James
    JOURNAL OF CHILD NEUROLOGY, 2011, 26 (06) : 703 - 706
  • [50] Lassa fever encephalopathy:: Lassa virus in cerebrospinal fluid but not in serum
    Günther, S
    Weisner, B
    Roth, A
    Grewing, T
    Asper, M
    Drosten, C
    Emmerich, P
    Petersen, J
    Wilczek, M
    Schmitz, H
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (03): : 345 - 349